Counterfeit or diverted drugs pose serious harm to patients. They can even be fatal. The rising incidence of pharmaceutical counterfeiting—$200B globally—has resulted in varying legislation worldwide to secure global supply chains. But serialization compliance alone is not enough.
End-to-end product tracking and authentication—from point of manufacture to point of dispensation—is essential to ensure compliance, control quality, stop revenue loss and keep people safe. Achieving this level of traceability is not easy.
The world’s leading pharmaceutical companies rely on Systech, the serialization pioneer, to secure their distribution channels. Systech uniquely combines powerful machine vision with flexible cloud-based solutions into one comprehensive platform to provide complete item transfer visibility across the entire supply chain.
Interested? Learn More
INFOGRAPHIC
Pharmaceutical companies can’t afford to ignore drug diversion and counterfeiting. Serialization compliance is not enough. What are you going to do about it?
INDUSTRY STUDY
A team of experts explore the Drug Supply Chain Security Act and blockchain to meet the 2023 requirement for interoperable, electronic tracing
Gartner's Framework
We've partnered with Gartner to offer you their 'Framework for End-to-End Supply Chain Traceability. This guide will help you assess the scope of your current end-to-end supply chain networks.